Showing results (111-120 of 198) with videos related to
Sort By:
Pageof 20
European Heart Journal|December 5, 2013
Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48Deepak K Gupta, Amil M Shah, Robert P Giugliano, et al.JAMA Cardiology|January 19, 2017
The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation: A ReviewPaul L Hess, Jeff S Healey, Christopher B Granger, et al.European Heart Journal. Cardiovascular Pharmacotherapy|December 28, 2021
Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48Marc P Bonaca, Elliott M Antman, Jonathan W Cunningham, et al.American Heart Journal|March 5, 2013
Central versus local adjudication of myocardial infarction in a cardiac biomarker trialStephen W Smith, Deborah B Diercks, John T Nagurney, et al.Circulation. Cardiovascular Quality and Outcomes|June 3, 2024
Application of the Win Ratio Method in the ENGAGE AF-TIMI 48 Trial Comparing Edoxaban With Warfarin in Patients With Atrial FibrillationBrian A Bergmark, Jeong-Gun Park, Rose A Hamershock, et al.Circulation|February 15, 2021
Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 TrialThomas A Zelniker, Maddalena Ardissino, Felicita Andreotti, et al.Lancet (London, England)|March 15, 2015
Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trialJessica L Mega, Joseph R Walker, Christian T Ruff, et al.Stroke|July 9, 2016
Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)Natalia S Rost, Robert P Giugliano, Christian T Ruff, et al.Journal of the American College of Cardiology|July 13, 2019
Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver DiseaseArman Qamar, Elliott M Antman, Christian T Ruff, et al.Journal of the American Heart Association|August 27, 2024
Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient-Level Meta-Analysis From COMBINE AFLinda S Johnson, Alexander P Benz, Ashkan Shoamanesh, et al.Pageof 20